About Baudax bio
Baudax Bio: Revolutionizing Specialty Pharmaceuticals for Hospitals and Ambulatory Care Settings
Baudax Bio is a specialty pharmaceutical company that has been making waves in the healthcare industry with its innovative products designed specifically for hospitals and ambulatory care settings. The company's mission is to provide safe, effective, and affordable solutions to healthcare providers that improve patient outcomes while reducing costs.
Founded in 2019, Baudax Bio has quickly established itself as a leader in the field of specialty pharmaceuticals. The company's product portfolio includes both branded and generic drugs that are used to treat a wide range of conditions such as pain management, anesthesia, and critical care.
One of the key factors that sets Baudax Bio apart from other pharmaceutical companies is its focus on developing products that are tailored to meet the unique needs of hospitals and ambulatory care settings. This approach allows healthcare providers to deliver better quality care while also reducing costs associated with hospital readmissions or complications.
Baudax Bio's flagship product is ANJESO® (meloxicam) injection, which was approved by the FDA in February 2020 for use in adults who require moderate-to-severe pain management. ANJESO® is a non-opioid medication that provides long-lasting pain relief without the risk of addiction or other adverse effects associated with opioids.
Another notable product from Baudax Bio is BELBUCA® (buprenorphine) buccal film, which was approved by the FDA in 2015 for use in patients with chronic pain who require around-the-clock opioid therapy. BELBUCA® offers an alternative treatment option for patients who may not be able to tolerate traditional oral medications due to gastrointestinal issues or other concerns.
In addition to these products, Baudax Bio also offers a range of generic medications used in anesthesia and critical care settings such as dexmedetomidine hydrochloride injection USP (Precedex®) and fentanyl citrate injection USP (Sublimaze®).
Baudax Bio's commitment to innovation and patient care is reflected in its ongoing research and development efforts. The company has a robust pipeline of products in various stages of development, including a new formulation of ANJESO® that is designed to provide even longer-lasting pain relief.
Overall, Baudax Bio is a company that is dedicated to improving the lives of patients by providing safe, effective, and affordable solutions for hospitals and ambulatory care settings. With its focus on innovation, patient care, and cost-effectiveness, Baudax Bio is poised to continue making significant contributions to the healthcare industry for years to come.